Grasslanz Technology Australia holds a licence (DIR 176) for a GM plant field trial. In 2024-25 the Regulator found it had failed to meet the licence's inspection timeframes on 12 occasions and its reporting timeframes on nine, and had cleaned and replanted a trial site without notifying the Regulator. The response recorded in the annual report is that the company "has been reminded of its obligation to ensure licence conditions are understood and met". The Act allows the Regulator to give written directions, to suspend or cancel a licence, and to seek a Federal Court injunction. Its compliance policy describes all of these as escalation options.
Sources: Annual Report 2024-25, pp 55-57; Gene Technology Act 2000 ss 68, 146, 147; OGTR Compliance and Enforcement Policy (April 2016).